BSG and colorectal cancer: Blocking CD147 or CD147-knockdown could induce cell apoptosis of colorectal cancer cells and delayed tumor growth (Baba et al., 2008; Ismail et al., 2016), which suggested targeting CD147 could be used as a potential strategy for colorectal cancer therapy.